Business Description
Pure Biologics SA
ISIN : PLPRBLG00010
Share Class Description:
STU:PQB: Ordinary SharesCompare
Compare
Traded in other countries / regions
PUR.PolandPQB.Germany IPO Date
2018-12-17Description
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.4 | |||||
| Equity-to-Asset | -0.16 | |||||
| Debt-to-Equity | -4.31 | |||||
| Debt-to-EBITDA | -0.52 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -9.15 | |||||
| Beneish M-Score | -5.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -56 | |||||
| 3-Year EBITDA Growth Rate | -17.1 | |||||
| 3-Year EPS without NRI Growth Rate | -14.3 | |||||
| 3-Year FCF Growth Rate | -84.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.07 | |||||
| 9-Day RSI | 47.89 | |||||
| 14-Day RSI | 51.81 | |||||
| 6-1 Month Momentum % | 131.28 | |||||
| 12-1 Month Momentum % | 39.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.95 | |||||
| Quick Ratio | 1.95 | |||||
| Cash Ratio | 0.55 | |||||
| Days Sales Outstanding | 1682.17 | |||||
| Days Payable | 466.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.2 | |||||
| Shareholder Yield % | -19.91 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -2439.13 | |||||
| Operating Margin % | -40678.26 | |||||
| Net Margin % | -48724.64 | |||||
| FCF Margin % | -23568.75 | |||||
| ROE % | -269.69 | |||||
| ROA % | -66 | |||||
| ROIC % | -75.84 | |||||
| 3-Year ROIIC % | 619.41 | |||||
| ROC (Joel Greenblatt) % | -143.93 | |||||
| ROCE % | -78.75 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1262.5 | |||||
| EV-to-EBIT | -3.02 | |||||
| EV-to-EBITDA | -3.56 | |||||
| EV-to-Revenue | 1327.78 | |||||
| EV-to-FCF | -6.06 | |||||
| Earnings Yield (Greenblatt) % | -33.07 | |||||
| FCF Yield % | -16.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pure Biologics SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.016 | ||
| EPS (TTM) (€) | -2.44 | ||
| Beta | 2.5 | ||
| Volatility % | 187.27 | ||
| 14-Day RSI | 51.81 | ||
| 14-Day ATR (€) | 0.399506 | ||
| 20-Day SMA (€) | 5.012 | ||
| 12-1 Month Momentum % | 39.83 | ||
| 52-Week Range (€) | 1.166 - 6.66 | ||
| Shares Outstanding (Mil) | 3.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pure Biologics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pure Biologics SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pure Biologics SA Frequently Asked Questions
What is Pure Biologics SA(STU:PQB)'s stock price today?
The current price of STU:PQB is €5.12. The 52 week high of STU:PQB is €6.66 and 52 week low is €1.17.
When is next earnings date of Pure Biologics SA(STU:PQB)?
The next earnings date of Pure Biologics SA(STU:PQB) is .
Does Pure Biologics SA(STU:PQB) pay dividends? If so, how much?
Pure Biologics SA(STU:PQB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers